CN103110918B

CN103110918B - Medicine for treating upper respiratory infection

Info

Publication number: CN103110918B
Application number: CN201310059447.1A
Authority: CN
Inventors: 周艳珍
Original assignee: Individual
Current assignee: Individual
Priority date: 2013-02-26
Filing date: 2013-02-26
Publication date: 2014-01-29
Anticipated expiration: 2033-02-26
Also published as: CN103110918A

Abstract

The invention relates to a medicine for treating upper respiratory infection. The medicine is prepared by crude medical materials in parts by weight as follows: 5-10 parts of radix scrophulariae, 10-20 parts of rhizoma zingiberis, 20-30 parts of dogwood, 10-20 parts of platycodon grandiflorum, 15-25 parts of radix angelicae, 5-15 parts of inula flower, 10-20 parts of akebia fruit, 10-20 parts of the root bark of white mulberry, 20-30 parts of herba carotis, 5-15 parts of lophatherum gracile, 1-10 parts of cortex periplocae, 10-20 parts of jasmine, 15-25 parts of radix curcumae, 20-30 parts of fructus forsythiae, 10-20 parts of emblic leafflower fruit, 1-20 parts of fructus kochiae, 1-20 parts of pyrrosia lingua, 1-10 parts of saururus chinensis, 10-20 parts of cortex acanthopanacis, 10-20 parts of fewflower lysionotus herb, 20-30 parts of polygala tenuifolia, 10-20 parts of moutan bark and 10-20 parts of quispualis indica. The medicine for treating upper respiratory infection provided by the invention is explicit in curative effect, quick in effect, free from toxic and side effects and very suitable for large-scale application.

Description

A kind of medicine for the treatment of upper respiratory tract infection

Technical field

The present invention relates to Respiratory Medicine field, specifically, relate to a kind of medicine for the treatment of upper respiratory tract infection.

Background technology

Upper respiratory tract infection refers to from nasal cavity to the acutely inflamed general name between throat, is modal infectious disease.90% left and right is caused by virus, after antibacterial infects and is often secondary to viral infection.These disease four seasons, any age all can fall ill, and by containing the virulent spittle, droplet, or propagate through the apparatus polluting.Often when Abwehrkraft des Koepers reduces, as catch cold, tired, the situation such as drench with rain, the former virus that has existed or invaded by the external world is or/and antibacterial, ramp breeding, causes infecting.Chang Jifa bronchitis, pneumonia, nasal sinusitis, a few peoples can complicated with acute myocarditis, nephritis, rheumatic fever etc.

At present, for the research of the medicine of upper respiratory tract infection constantly in research.

Summary of the invention

The object of this invention is to provide a kind of medicine for the treatment of upper respiratory tract infection.

In order to realize object of the present invention, the invention provides a kind of medicine for the treatment of upper respiratory tract infection, it is to be made by weight by following bulk drugs: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Radix Angelicae Dahuricae 15-25 part, Flos Inulae 5-15 part, Fructus Akebiae 10-20 part, Cortex Mori 10-20 part, Lagotis clarkei Hook. F (Lagotis brevituba Maxim.) 20-30 part, Herba Lophatheri 5-15 part, Cortex Periplocae 1-10 part, Fructus Gardeniae 10-20 part, Radix Curcumae 15-25 part, Fructus Forsythiae 20-30 part, Fructus Phyllanthi 10-20 part, Fructus Kochiae 1-20 part, Folium Pyrrosiae 1-20 part, Rhizoma Saururi (Herba Saururi) 1-10 part, Cortex Acanthopancis 10-20 part, Herba Lysionoti Pauciflori 10-20 part, Radix Polygalae 20-30 part, Cortex Moutan 10-20 part and Fructus Quisqualis 10-20 part.

Preferably, the medicine for the treatment of upper respiratory tract infection of the present invention is to be made by weight by following bulk drugs: 15 parts of 7 parts of Radix Scrophulariaes, 15 parts of Rhizoma Zingiberiss, 25 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 20 parts of the Radixs Angelicae Dahuricae, 10 parts of Flos Inulaes, 15 parts of Fructus Akebiae, 15 parts of Cortex Mori, 25 parts of Lagotis clarkei Hook. F (Lagotis brevituba Maxim.), 10 parts of Herba Lophatheris, 5 parts of Cortex Periplocaes, 15 parts of Fructus Gardeniaes, 20 parts of Radix Curcumaes, 25 parts of Fructus Forsythiaes, 15 parts of Fructus Phyllanthis, 10 parts of the Fructus Kochiae, 15 parts of Folium Pyrrosiaes, 5 parts of Rhizoma Saururi (Herba Saururi)s, 15 parts of Cortex Acanthopanciss, 15 parts of Herba Lysionoti Paucifloris, 25 parts of Radix Polygalaes, 15 parts of Cortex Moutans and Fructus Quisqualis.

More preferably, described medicine can be made tablet, dispersible tablet, buccal tablet, powder or granule.

The curative effect of medicine for the treatment of upper respiratory tract infection of the present invention is clear and definite, and effect is rapid, and has no side effect, and is very suitable for extensive use.

The specific embodiment

Below the invention will be further described for the description by the specific embodiment, but this is not limitation of the present invention, those skilled in the art are according to basic thought of the present invention, can make various modifications or improvement, but only otherwise depart from basic thought of the present invention, all within the scope of the present invention.

The preparation of embodiment 1 powder of the present invention

Get 70 grams of Radix Scrophulariaes, 150 grams of Rhizoma Zingiberiss, 250 grams of Fructus Corni, 150 grams of Radix Platycodoniss, 200 grams of the Radixs Angelicae Dahuricae, 100 grams of Flos Inulaes, 150 grams of Fructus Akebiae, 150 grams of Cortex Mori, 250 grams of Lagotis clarkei Hook. F (Lagotis brevituba Maxim.), 100 grams of Herba Lophatheris, 50 grams of Cortex Periplocaes, 150 grams of Fructus Gardeniaes, 200 grams of Radix Curcumaes, 250 grams of Fructus Forsythiaes, 150 grams of Fructus Phyllanthis, 100 grams of the Fructus Kochiae, 150 grams of Folium Pyrrosiaes, 50 grams of Rhizoma Saururi (Herba Saururi)s, 150 grams of Cortex Acanthopanciss, 150 grams of Herba Lysionoti Paucifloris, 250 grams of Radix Polygalaes, 150 grams of 150 grams of Cortex Moutans and Fructus Quisqualis, pulverize, cross 100 mesh sieves, then add 350 grams, 250 grams of lactose and mannitol, mix, pack in 200 bags and get final product.

Experimental example

According to national higher medical institution teaching material < < internal medicine > > (Ye Rengao, Lu Zaiying. internal medicine [M]. the 6th edition. Beijing: People's Health Publisher, 2004.12.) and People's Medical Officer Press < < clinical disease diagnosis according to cure improvement standard > > (Sun Chuanxing. clinical disease diagnosis is according to curing improvement standard [S]. the 2nd edition. Beijing: People's Medical Officer Press, 1998.4.) formulate following standard: 1, heating (more than body temperature 38 degree), with aversion to cold, headache, pharyngalgia, cough, xerostomia is thirsty, 2, tongue tip side of red, white or yellow thin fur, 3, lab testing: hemogram raises, neutrality moves to left.Allly meet above three persons and can be diagnosed as and suffer from upper respiratory tract infection.

Choose patient's 60 examples that meet above-mentioned standard, male 30 examples wherein, female's 30 examples; Minimal ages 14 years old, maximum 56 years old age, 37 years old mean age.

With the powder making in embodiment 1, treat, wherein one day 3 times, each oral one bag, treating 7 days is a course for the treatment of.

Efficacy assessment standard

Effective: all front two standards disappeared with interior at 2 days, a rear standard the 4th day is with the normal person of interior recovery.Take a turn for the better: all front two standards disappeared in 2-3 days, and latter one was recovered normal person at 4-6 days.Invalid: front two disappear with interior for 3 days, rear one is recovered normal person on the 6th day later.

Through the treatment of a course for the treatment of, find that front two standards of all patients disappeared with interior at 2 days, it is normal that a rear standard is recovered on the 3rd day, therefore all meets effective efficacy assessment standard.And during whole treatment, do not observe obvious untoward reaction.

Claims

1. a medicine for the treatment of upper respiratory tract infection, it is characterized in that, it is to be made by weight by following bulk drugs: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Radix Angelicae Dahuricae 15-25 part, Flos Inulae 5-15 part, Fructus Akebiae 10-20 part, Cortex Mori 10-20 part, Lagotis clarkei Hook. F (Lagotis brevituba Maxim.) 20-30 part, Herba Lophatheri 5-15 part, Cortex Periplocae 1-10 part, Fructus Gardeniae 10-20 part, Radix Curcumae 15-25 part, Fructus Forsythiae 20-30 part, Fructus Phyllanthi 10-20 part, Fructus Kochiae 1-20 part, Folium Pyrrosiae 1-20 part, Rhizoma Saururi (Herba Saururi) 1-10 part, Cortex Acanthopancis 10-20 part, Herba Lysionoti Pauciflori 10-20 part, Radix Polygalae 20-30 part, Cortex Moutan 10-20 part and Fructus Quisqualis 10-20 part.

2. the medicine for the treatment of upper respiratory tract infection according to claim 1, it is characterized in that, it is to be made by weight by following bulk drugs: 15 parts of 7 parts of Radix Scrophulariaes, 15 parts of Rhizoma Zingiberiss, 25 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 20 parts of the Radixs Angelicae Dahuricae, 10 parts of Flos Inulaes, 15 parts of Fructus Akebiae, 15 parts of Cortex Mori, 25 parts of Lagotis clarkei Hook. F (Lagotis brevituba Maxim.), 10 parts of Herba Lophatheris, 5 parts of Cortex Periplocaes, 15 parts of Fructus Gardeniaes, 20 parts of Radix Curcumaes, 25 parts of Fructus Forsythiaes, 15 parts of Fructus Phyllanthis, 10 parts of the Fructus Kochiae, 15 parts of Folium Pyrrosiaes, 5 parts of Rhizoma Saururi (Herba Saururi)s, 15 parts of Cortex Acanthopanciss, 15 parts of Herba Lysionoti Paucifloris, 25 parts of Radix Polygalaes, 15 parts of Cortex Moutans and Fructus Quisqualis.